Shawn Lynch
Shawn Lynch has resigned from his position as CFO of T2 Biosystems, effective immediately. According to a Form 8K the company filed this week with the US Securities and Exchange Commission, Lynch left for personal reasons and not as the result of a disagreement with management or the board.
Jay Shendure, Shankar Balasubramanian, Wolf Reik, Anjana Rao
Cambridge Epigenetix has appointed Jay Shendure, Shankar Balasubramanian, Wolf Reik, and Anjana Rao to its newly formed scientific advisory board. Balasubramanian, who co-founded the company and invented its proprietary 'TruMethyl' technology, will serve as chair. He is also the Herchel Smith Professor of Medicinal Chemistry at the University of Cambridge. Reik currently serves as head and associate director of the epigenetics program at the Babraham Institute in Cambridge. He also serves as scientific advisor to Cambridge Epigenetix, is an honorary professor of epigenetics at the University of Cambridge, and serves on the associate faculty at the Wellcome Trust Sanger Institute. Rao serves as professor and head of the Division of Signaling and Gene Expression at the La Jolla Institute and the Sanford Consortium for Regenerative Medicine in San Diego. Shendure serves as professor of genome sciences at the University of Washington.
Paul Dark, Angela Caliendo, Stephan Harbarth, Romney Humphries
DNAe has appointed Paul Dark, Angela Caliendo, Stephan Harbarth, and Romney Humphries to its newly formed clinical advisory board. Dark serves as chair of critical care medicine at the University of Manchester. He also works as a national research lead in critical care for the National Institute of Health Research and as a visiting professor at King's College London. Caliendo serves as a professor, executive vice chair of the department of medicine, and a director of the division of general internal medicine at the Warren Alpert Medical School of Brown University. She also serves as editor for the Journal of Clinical Microbiology, chair of the Microbiology Medical Devices panel for the FDA, and serves on the board of directors of the Infectious Diseases Society of America. Harbarth serves as an associate professor at the University of Geneva and senior consultant at the Geneva University Hospitals. Humphries is an assistant professor in the department of pathology and laboratory medicine in the David Geffen School of Medicine at the University of California, Los Angeles.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.